Search results
Results from the WOW.Com Content Network
Amblyopia. Anisometropia is a condition in which a person's eyes have substantially differing refractive power. [ 1] Generally, a difference in power of one diopter (1D) is the threshold for diagnosis of the condition. [ 2][ 3] Patients may have up to 3D of anisometropia before the condition becomes clinically significant due to headache, eye ...
Idiopathic hypersomnia (IH) is a neurological disorder which is characterized primarily by excessive sleep and excessive daytime sleepiness (EDS). [ 1] Idiopathic hypersomnia was first described by Bedrich Roth in 1976, and it can be divided into two forms: polysymptomatic and monosymptomatic. [ 2][ 3] The condition typically becomes evident in ...
Convergence insufficiency. Convergence Insufficiency. Other names. Convergence disorder. Specialty. Ophthalmology, optometry. Convergence insufficiency is a sensory and neuromuscular anomaly of the binocular vision system, characterized by a reduced ability of the eyes to turn towards each other, or sustain convergence .
Aniseikonia. Aniseikonia is an ocular condition where there is a significant difference in the perceived size of images. It can occur as an overall difference between the two eyes, or as a difference in a particular meridian. [ 1] If the ocular image size in both eyes are equal, the condition is known as iseikonia. [ 2]
Even with insurance coverage, weight loss medication costs are still "highly variable." But they typically cost the same as any other prescription medicine in your benefit plan, Dr. Wantuck says.
Out-of-pocket costs for some prescription weight-loss drugs can hover around $1,000 per ... "The real problem in America is that obesity as a disease state is not a standard benefit on insurance.
Familial amyloid polyneuropathy, also called transthyretin-related hereditary amyloidosis, transthyretin amyloidosis abbreviated also as ATTR (hereditary form), or Corino de Andrade's disease, [ 1] is an autosomal dominant [ 2] neurodegenerative disease. It is a form of amyloidosis, and was first identified and described by Portuguese ...
In 2021, House lawmakers introduced The Treat and Reduce Obesity Act, which would have allowed the federal government to expand Medicare Part D coverage to include weight loss medications. The ...